The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Endocrine functions of bone in mineral metabolism regulation
Open accessAbstract
Given the dramatic increase in skeletal size during growth, the need to preserve skeletal mass during adulthood, and the large capacity of bone to store calcium and phosphate, juxtaposed with the essential role of phosphate in energy metabolism and the adverse effects of hyperphosphatemia, it is not surprising that a complex systems biology has evolved that permits cross-talk between bone and other organs to adjust phosphate balance and bone mineralization in response to changing physiological requirements. This review examines the newly discovered signaling pathways involved in the endocrine functions of bone, such as those mediated by the phosphaturic and 1,25(OH)2D-regulating hormone FGF23, and the broader systemic effects associated with abnormalities of calcium and phosphate homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These cells are able to regulate phosphate metabolism by the production of FGF23, which acts on other organs including parathyroid gland and kidneys to reduce the circulating levels of phosphates [208, 209].”
From Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells (2015) · cites this paper as [208]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
Block, G. A., Klassen, P., Lazarus, J. M., Ofsthun, N. J., Lowrie, E. G., & Chertow, G. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000133041.27682.a2 · Cited by 2,684
Suppression of Aging in Mice by the Hormone Klotho
Kurosu, H., Yamamoto, M., Clark, J. D., Pastor, J. V., Nandi, A., Gurnani, P., McGuinness, O. P., Chikuda, H., Yamaguchi, M., Kawaguchi, H., et al. (2005) · Science · doi:10.1126/science.1112766 · Cited by 1,935
Klotho converts canonical FGF receptor into a specific receptor for FGF23
Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., & Yamashita, T. (2006) · Nature · doi:10.1038/nature05315 · Cited by 1,865
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
Gutiérrez, O. M., Mannstadt, M., Isakova, T., Rauh‐Hain, J. A., Tamez, H. E., Shah, A., Smith, K. T., Lee, H., Thadhani, R., Jüppner, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706130 · Cited by 1,729
Shimada, T., Kakitani, M., Yamazaki, Y., Hasegawa, H., Takeuchi, Y., Fujita, T., Fukumoto, S., Tomizuka, K., & Yamashita, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19081 · Cited by 1,503
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
Shimada, T., Mizutani, S., Muto, T., Yoneya, T., Hino, R., Takeda, S., Takeuchi, Y., Fujita, T., Fukumoto, S., & Yamashita, T. (2001) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.101545198 · Cited by 1,391
Regulation of Fibroblast Growth Factor-23 Signaling by Klotho
Kurosu, H., Ogawa, Y., Miyoshi, M., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Baum, M. G., Schiavi, S. C., Hu, M. C., Moe, O. W., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c500457200 · Cited by 1,381
Shimada, T., Kakitani, M., Yamazaki, Y., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419081 · Cited by 1,368
Feng, J. Q., Ward, L. M., Liu, S., Lu, Y., Xie, Y., Yuan, B., Yu, X., Rauch, F., Davis, S. I., Zhang, S., et al. (2006) · Nature Genetics · doi:10.1038/ng1905 · Cited by 1,199
Self-citationEvolution of the Fgf and Fgfr gene families.
Itoh, N., & Ornitz, D. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.08.007 · Cited by 1,123
Francis, F., Hennig, S., Korn, B., Reinhardt, R., de Jong, P., Poustka, A. J., Lehrach, H. R., Rowe, P. S., Goulding, J. N., Summerfield, T. C., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-130 · Cited by 1,095
The parathyroid is a target organ for FGF23 in rats
Ben‐Dov, I. Z., Galitzer, H., Lavi-Moshayoff, V., Goetz, R. M., Kuro‐o, M., Mohammadi, M., Sirkis, R., Naveh‐Many, T., & Silver, J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32409 · Cited by 951
Gutiérrez, O. M., Isakova, T., Rhee, E. P., Shah, A., Holmes, J., Collerone, G., Diaeresis]ppner, H. J., & Wolf, M. S. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010052 · Cited by 920
Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia
Jonsson, K. B., Zahradnik, R. J., Larsson, T. E., White, K. E., Sugimoto, T., Imanishi, Y., Yamamoto, T., Hampson, G., Koshiyama, H., Ljunggren, Ö., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020881 · Cited by 904
Kurosu, H., Choi, M., Ogawa, Y., Dickson, A. S., Goetz, R., Eliseenkova, A. V., Mohammadi, M., Rosenblatt, K. P., Kliewer, S. A., & Kuro-o, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704165200 · Cited by 748
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting
Riminucci, M., Collins, M. T., Fedarko, N. S., Cherman, N., Corsi, A., White, K. E., Waguespack, S. G., Gupta, A., Hannon, T. S., Econs, M. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18399 · Cited by 656
Fibroblast Growth Factor 23 Is a Counter-Regulatory Phosphaturic Hormone for Vitamin D
Liu, S., Tang, W., Zhou, J., Stubbs, J. R., Luo, Q., Pi, M., & Quarles, L. D. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005111185 · Cited by 641
Self-citationβKlotho is required for metabolic activity of fibroblast growth factor 21
Ogawa, Y., Kurosu, H., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Goetz, R., Eliseenkova, A. V., Mohammadi, M., & Kuro-o, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701600104 · Cited by 617
Beck, L., Karaplis, A. C., Amizuka, N., Hewson, A. S., Ozawa, H., & Tenenhouse, H. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5372 · Cited by 607
Murshed, M., Harmey, D., Millán, J. L., McKee, M. D., & Karsenty, G. (2005) · Genes & Development · doi:10.1101/gad.1276205 · Cited by 599
Chen, C.-D., Podvin, S., Gillespie, E., Leeman, S. E., & Abraham, C. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709805104 · Cited by 563
Yamashita, T., Yoshioka, M., & Itoh, N. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3696 · Cited by 553
Goetz, R. M., Beenken, A., Ibrahimi, O. A., Kalinina, J., Olsen, S. K., Eliseenkova, A. V., Xu, C.-F., Neubert, T. A., Zhang, F., Linhardt, R. J., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02249-06 · Cited by 550
Sitara, D., Razzaque, M., Hesse, M., Yoganathan, S., Taguchi, T., Erben, R., Jüppner, H., & Lanske, B. (2004) · Matrix Biology · doi:10.1016/j.matbio.2004.09.007 · Cited by 528
Lorenz‐Depiereux, B., Bastepe, M., Benet‐Pagès, A., Amyere, M., Wagenstaller, J., Mueller-Barth, U., Badenhoop, K. W. J., Kaiser, S., Rittmaster, R. S., Shlossberg, A. H., et al. (2006) · Nature Genetics · doi:10.1038/ng1868 · Cited by 524
Ferrari, S. L., Bonjour, J.-P., & Rizzoli, R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1039 · Cited by 518
Regulation of Fibroblastic Growth Factor 23 Expression but Not Degradation by PHEX
Liu, S., Guo, R., Simpson, L. G., Xiao, Z.-S., Burnham, C. E., & Quarles, L. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304544200 · Cited by 505
Self-citationTsujikawa, H., Kurotaki, Y., Fujimori, T., Fukuda, K., & Nabeshima, Y. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0048 · Cited by 501
Larsson, T. E., Marsell, R., Schipani, E., Ohlsson, C., Ljunggren, Ö., Tenenhouse, H. S., Jüppner, H., & Jonsson, K. B. (2004) · Endocrinology · doi:10.1210/en.2003-1768 · Cited by 497
Pathogenic role of Fgf23 in Hyp mice
Liu, S., Zhou, J., Tang, W., Jiang, X., Rowe, D. W., & Quarles, L. D. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00008.2006 · Cited by 494
Self-citationA homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis
Ichikawa, S., Imel, E. A., Kreiter, M. L., Yu, X., Mackenzie, D. S., Sorenson, A. H., Goetz, R. M., Mohammadi, M., White, K. E., & Econs, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31330 · Cited by 491
An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.
Benet-Pagès, A., Orlik, P., Strom, T., & Lorenz-Depiereux, B. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi034 · Cited by 486
Bergwitz, C., Roslin, N. M., Tieder, M., Loredo‐Osti, J., Bastepe, M., Abu-Zahra, H., Frappier, D., Burkett, K. M., Carpenter, T. O., Anderson, D., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/499409 · Cited by 485
Krajisnik, T., Björklund, P., Marsell, R., Ljunggren, Ö., Åkerström, G., Jonsson, K. B., Westin, G., & Larsson, T. E. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0267 · Cited by 473
Circulating FGF-23 Is Regulated by 1α,25-Dihydroxyvitamin D3 and Phosphorus in Vivo
Saitô, H., Maeda, A., Ohtomo, S., Hirata, M., Kusano, K., Kato, S., Ogata, E., Segawa, H., Miyamoto, K., & Fukushima, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408903200 · Cited by 468
Six Genes Expressed in Bones and Teeth Encode the Current Members of the SIBLING Family of Proteins
Fisher, L. W., & Fedarko, N. S. (2003) · Connective Tissue Research · doi:10.1080/03008200390152061 · Cited by 467
Ma, Y. L., Cain, R. L., Halladay, D. L., Yang, X., Zeng, Q., Miles, R. R., Chandrasekhar, S., Martin, T. J., & Onyia, J. E. (2001) · Endocrinology · doi:10.1210/endo.142.9.8356 · Cited by 428
Perwad, F., Azam, N., Zhang, M. Y. H., Yamashita, T., Tenenhouse, H. S., & Portale, A. A. (2005) · Endocrinology · doi:10.1210/en.2005-0777 · Cited by 424
Functional evolutionary history of the mouse Fgf gene family
Itoh, N., & Ornitz, D. M. (2007) · Developmental Dynamics · doi:10.1002/dvdy.21388 · Cited by 416
How Fibroblast Growth Factor 23 Works
Liu, S., & Quarles, L. D. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007010068 · Cited by 415
Self-citationSaitô, H., Kusano, K., Kinosaki, M., Ito, H., Hirata, M., Segawa, H., Miyamoto, K., & Fukushima, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207872200 · Cited by 412
α-Klotho as a Regulator of Calcium Homeostasis
Imura, A., Tsuji, Y., Murata, M., Maeda, R., Kubota, K., Iwano, A., Obuse, C., Togashi, K., Tominaga, M., Kita, N., et al. (2007) · Science · doi:10.1126/science.1135901 · Cited by 390
Hypophosphatemia: an evidence-based approach to its clinical consequences and management
Amanzadeh, J., & Reilly, R. F. (2006) · Nature Reviews Nephrology · doi:10.1038/ncpneph0124 · Cited by 387
Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism
Shimada, T., Yamazaki, Y., Takahashi, M., Hasegawa, H., Urakawa, I., Oshima, T., Ono, K., Kakitani, M., Tomizuka, K., Fujita, T., et al. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00474.2004 · Cited by 359
Serum FGF23 Levels in Normal and Disordered Phosphorus Homeostasis
Weber, T. J., Liu, S., Indridason, Ó. S., & Quarles, L. D. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.7.1227 · Cited by 353
Self-citationImmunohistochemical Localization of Klotho Protein in Brain, Kidney, and Reproductive Organs of Mice
Li, S.-A., Watanabe, M., Yamada, H., Nagai, A., Kinuta, M., & Takei, K. (2004) · Cell Structure and Function · doi:10.1247/csf.29.91 · Cited by 351
Razzaque, M. S., Sitara, D., Taguchi, T., St‐Arnaud, R., & Lanske, B. (2006) · The FASEB Journal · doi:10.1096/fj.05-5432fje · Cited by 345
Suzuki, M., Uehara, Y., Motomura-Matsuzaka, K., Oki, J., Koyama, Y., Kimura, M., Asada, M., Komi-Kuramochi, A., Oka, S., & Toru, T. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0313 · Cited by 345
FGF-23 Inhibits Renal Tubular Phosphate Transport and Is a PHEX Substrate
Bowe, A. E., Finnegan, R., de Beur, S. M. J., Cho, J., Levine, M. A., Kumar, R., & Schiavi, S. C. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5084 · Cited by 339
Masuyama, R., Stockmans, I., Torrekens, S., Looveren, R. V., Maes, C., Carmeliet, P., Bouillon, R., & Carmeliet, G. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29463 · Cited by 332
Bai, X., Miao, D., Li, J., Goltzman, D., & Karaplis, A. C. (2004) · Endocrinology · doi:10.1210/en.2004-0233 · Cited by 329
Mutations that Cause Osteoglophonic Dysplasia Define Novel Roles for FGFR1 in Bone Elongation
White, K. E., Cabral, J. M., Davis, S. I., Fishburn, T., Evans, W., Ichikawa, S., Fields, J., Yu, X., Shaw, N. J., McLellan, N., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/427956 · Cited by 328
Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein 1
Shiraki-Iida, T., Aizawa, H., Matsumura, Y., Sekine, S., Iida, A., Anazawa, H., Nagai, R., Kuro‐o, M., & Nabeshima, Y.-I. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00127-6 · Cited by 313
Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent
Berndt, T. J., Craig, T. A., Bowe, A. E., Vassiliadis, J., Reczek, D., Finnegan, R., de Beur, S. M. J., Schiavi, S. C., & Kumar, R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18563 · Cited by 292
Liver-specific Activities of FGF19 Require Klotho beta
Lin, B. C., Wang, M., Blackmore, C. A., & Desnoyers, L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704244200 · Cited by 288
Stubbs, J. R., Liu, S., Tang, W., Zhou, J., Wang, Y., Yao, X., & Quarles, L. D. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006121385 · Cited by 275
Self-citationBai, X., Miao, D., Goltzman, D., & Karaplis, A. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210490200 · Cited by 274
Corut, A., Şenyiğit, A., İşerı̇, S. A. U., Altın, S., Özçelik, U., Çalışır, H. C., Yıldırım, Z., Göçmen, A., & Tolun, A. (2006) · The American Journal of Human Genetics · doi:10.1086/508263 · Cited by 270
MEPE has the properties of an osteoblastic phosphatonin and minhibin
Rowe, P. S., Kumagai, Y., Gutierrez, G., Garrett, I. R., Blacher, R. W., Rosen, D., Cundy, J., Navvab, S., Chen, D., Drezner, M. K., et al. (2003) · Bone · doi:10.1016/j.bone.2003.10.005 · Cited by 268
Self-citationWang, H., Yoshiko, Y., Yamamoto, R., Minamizaki, T., Kozai, K., Tanne, K., Aubin, J. E., & Maeda, N. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080220 · Cited by 263
FGF23 is processed by proprotein convertases but not by PHEX
Benet‐Pagès, A., Lorenz‐Depiereux, B., Zischka, H., White, K. E., Econs, M. J., & Strom, T. M. (2004) · Bone · doi:10.1016/j.bone.2004.04.002 · Cited by 258
Dual Functional Roles of Dentin Matrix Protein 1
Narayanan, K., Ramachandran, A., Hao, J. J., He, G., Park, K. W., Cho, M., & George, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212700200 · Cited by 243
Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men
Nishida, Y., Taketani, Y., Yamanaka-Okumura, H., Imamura, F., Taniguchi, A., Sato, T., Shuto, E., Nashiki, K., Arai, H., Yamamoto, H., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5002000 · Cited by 243
Alpha-Klotho as a regulator of calcium homeostasis
Tsuji, Y. (2008) · Kyoto University Research Information Repository (Kyoto University) · Cited by 241
Yoshida, T., Fujimori, T., & Nabeshima, Y. (2002) · Endocrinology · doi:10.1210/endo.143.2.8657 · Cited by 240
Brownstein, C. A., Adler, F., Nelson-Williams, C. J., Iijima, J., Li, P., Imura, A., Nabeshima, Y., Reyes‐Múgica, M., Carpenter, T. O., & Lifton, R. P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712361105 · Cited by 239
Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi.
Hafner, C., van Oers, J. V., Vogt, T., Landthaler, M., Stoehr, R., Blaszyk, H., Hofstaedter, F., Zwarthoff, E., & Hartmann, A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28163 · Cited by 217
DMP1 depletion decreases bone mineralization in vivo: an FTIR imaging analysis
Ling, Y., Rios, H. F., Myers, E. R., Lu, Y., Feng, J. Q., & Boskey, A. L. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050815 · Cited by 216
Yamashita, T., Konishi, M., Miyake, A., Inui, K., & Itoh, N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202527200 · Cited by 215
Analysis of the Biochemical Mechanisms for the Endocrine Actions of Fibroblast Growth Factor-23
Yu, X., Ibrahimi, O. A., Goetz, R. M., Zhang, F., Davis, S. I., Garringer, H. J., Linhardt, R. J., Ornitz, D. M., Mohammadi, M., & White, K. E. (2005) · Endocrinology · doi:10.1210/en.2005-0670 · Cited by 213
cDNA Cloning and Expression of a Novel Human UDP- -acetyl-α-D-galactosamine
Bennett, E., Hassan, H., & Clausen, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17006 · Cited by 211
Kawata, T., Imanishi, Y., Kobayashi, K., Miki, T., Arnold, A., Inaba, M., & Nishizawà, Y. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070783 · Cited by 208
Hesse, M., Fröhlich, L. F., Zeitz, U., Lanske, B., & Erben, R. G. (2006) · Matrix Biology · doi:10.1016/j.matbio.2006.10.003 · Cited by 198
Anti-FGF23 Neutralizing Antibodies Show the Physiological Role and Structural Features of FGF23
Yamazaki, Y., Tamada, T., Kasai, N., Urakawa, I., Aono, Y., Hasegawa, H., Fujita, T., Kuroki, R., Yamashita, T., Fukumoto, S., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080417 · Cited by 195
Genetic Evidence of Serum Phosphate-Independent Functions of FGF-23 on Bone
Sitara, D., Kim, S., Razzaque, M. S., Bergwitz, C., Taguchi, T., Schüler, C., Erben, R. G., & Lanske, B. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000154 · Cited by 184
Yuan, B., Takaiwa, M., Clemens, T. L., Feng, J. Q., Kumar, R., Rowe, P. S., Xie, Y., & Drezner, M. K. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32702 · Cited by 178
Expression of SIBLINGs and Their Partner MMPs in Salivary Glands
Ogbureke, K. U. E., & Fisher, L. W. (2004) · Journal of Dental Research · doi:10.1177/154405910408300902 · Cited by 174
Martin, A., David, V., Laurence, J. S., Schwarz, P. M., Lafer, E. M., Hedge, A.-M., & Rowe, P. S. N. (2008) · Endocrinology · doi:10.1210/en.2007-1205 · Cited by 173
Carpenter, T. O., Ellis, B. K., Insogna, K. L., Philbrick, W. M., Sterpka, J., & Shimkets, R. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0357 · Cited by 158
Direct Binding of Integrin αvβ3 to FGF1 Plays a Role in FGF1 Signaling
Mori, S., Wu, C., Yamaji, S., Saegusa, J., Shi, B., Ma, Z., Kuwabara, Y., Lam, K. S., Isseroff, R. R., Takada, Y. K., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801213200 · Cited by 154
Sitara, D., Razzaque, M. S., St‐Arnaud, R., Huang, W. Y., Taguchi, T., Erben, R. G., & Lanske, B. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060329 · Cited by 153
Fisher, S. E., Black, G. C. M., Lloyd, S. E., Hatchwell, E., WRONG, O. M., Thakker, R. V., & Craig, I. (1994) · PubMed · Cited by 146
Pathogenic role of Fgf23 in Dmp1 -null mice
Liu, S., Zhou, J., Tang, W., Menard, R., Feng, J. Q., & Quarles, L. D. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90201.2008 · Cited by 144
Self-citationCorrelation between hyperphosphatemia and type II Na-Pi cotransporter activity in klotho mice
Segawa, H., Yamanaka, S., Ohno, Y., Onitsuka, A., Shiozawa, K., Aranami, F., Furutani, J., Tomoe, Y., Ito, M., Kuwahata, M., et al. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00248.2006 · Cited by 144
FGFR3 and FGFR4 Do not Mediate Renal Effects of FGF23
Liu, S., Vierthaler, L., Tang, W., Zhou, J., & Quarles, L. D. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007121301 · Cited by 143
Self-citationFeild, J. A., Zhang, L., Brun, K. A., Brooks, D. P., & Edwards, R. M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0666 · Cited by 143
A Deleterious Mutation in SAMD9 Causes Normophosphatemic Familial Tumoral Calcinosis
Topaz, O., Indelman, M., Chefetz, I., Geiger, D., Metzker, A., Altschuler, Y., Choder, M., Bercovich, D., Uitto, J., Bergman, R., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/508069 · Cited by 136
Fibroblast Growth Factor-23 Mutants Causing Familial Tumoral Calcinosis Are Differentially Processed
Larsson, T. E., Davis, S. I., Garringer, H. J., Mooney, S. D., Draman, M. S., Cullen, M. J., & White, K. E. (2005) · Endocrinology · doi:10.1210/en.2005-0431 · Cited by 134
Lu, Y., Ye, L., Yu, S., Zhang, S., Xie, Y., McKee, M. D., Li, Y. C., Kong, J., Eick, J. D., Dallas, S. L., et al. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.11.001 · Cited by 129
Dentin Matrix Protein 1 Initiates Hydroxyapatite Formation In Vitro
He, G., Dahl, T., Veis, A., & George, A. (2003) · Connective Tissue Research · doi:10.1080/03008200390181726 · Cited by 127
Intrinsic mineralization defect inHyp mouse osteoblasts
Xiao, Z., Crenshaw, M. A., Guo, R., Nesbitt, T., Drezner, M. K., & Quarles, L. D. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.4.e700 · Cited by 114
Self-citationRizzoli, R., Fleisch, H. A., & Bonjour, J. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108815 · Cited by 112
Differential effects ofNpt2agene ablation and X-linkedHypmutation on renal expression of Npt2c
Tenenhouse, H. S., Martel, J., Gauthier, C., Segawa, H., & Miyamoto, K. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00252.2003 · Cited by 110
Guo, R., & Quarles, L. D. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.7.1009 · Cited by 108
Self-citationGenetic Transmission of Tumoral Calcinosis: Autosomal Dominant with Variable Clinical Expressivity*
Lyles, K. W., Burkes, E. J., Ellis, G. J., LUCAS, K. J., Dolan, E. A., & Drezner, M. K. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-6-1093 · Cited by 105
Bai, X., Miao, D., Panda, D., Grady, S., McKee, M. D., Goltzman, D., & Karaplis, A. C. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0113 · Cited by 100
Campos, M., COUTURE, C., Hirata, I. Y., Juliano, M. A., Loisel, T. P., Crine, P., Juliano, L., Boileau, G., & Carmona, A. K. (2003) · Biochemical Journal · doi:10.1042/bj20030287 · Cited by 98
Ontogeny of Phex/PHEX Protein Expression in Mouse Embryo and Subcellular Localization in Osteoblasts
Thompson, D., Sabbagh, Y., Tenenhouse, H. S., Roche, P. C., Drezner, M. K., Salisbury, J. L., Grande, J. P., Poeschla, E. M., & Kumar, R. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.2.311 · Cited by 97
Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23
Marsell, R., Krajisnik, T., Göransson, H., Ohlsson, C., Ljunggren, Ö., Larsson, T. E., & Jonsson, K. B. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm672 · Cited by 94
Liu, S., Rowe, P. S., Vierthaler, L., Zhou, J., & Quarles, L. D. (2007) · Journal of Endocrinology · doi:10.1677/joe.1.07059 · Cited by 92
Self-citationOverexpression of Phex in Osteoblasts Fails to Rescue the Hyp Mouse Phenotype
Liu, S., Guo, R., Tu, Q., & Quarles, L. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107707200 · Cited by 91
Self-citationKlotho Protein Promotes Adipocyte Differentiation
Chihara, Y., Rakugi, H., Ishikawa, K., Ikushima, M., Maekawa, Y., Ohta, J., Kida, I., & Ogihara, T. (2006) · Endocrinology · doi:10.1210/en.2005-1529 · Cited by 90
Tissue inhibitor of metalloproteinase-4 instigates apoptosis in transformed cardiac fibroblasts
Tummalapalli, C. M., Heath, B. J., & Tyagi, S. C. (2001) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20010315)80:4 · Cited by 88
Liu, S., Tang, W., Zhou, J., Vierthaler, L., & Quarles, L. D. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00396.2007 · Cited by 86
Self-citationAnalysis of recombinant Phex: an endopeptidase in search of a substrate
Guo, R., Liu, S., Spurney, R. F., & Quarles, L. D. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.4.e837 · Cited by 81
Self-citationDisruption of klotho Gene Causes an Abnormal Energy Homeostasis in Mice
Mori, K., Yahata, K., Mukoyama, M., Suganami, T., Makino, H., Nagae, T., Masuzaki, H., Ogawa, Y., Sugawara, A., Nabeshima, Y.-I., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3864 · Cited by 65
Erben, R. G., Mayer, D., Weber, K., Jonsson, K. B., Jüppner, H., & Lanske, B. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050212 · Cited by 60
Tumor producing fibroblast growth factor 23 localized by two-staged venous sampling
van Boekel, G., Ruinemans‐Koerts, J., Joosten, F. B. M., Dijkhuizen, P. A., van Sorge, A., & de Boer, H. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0779 · Cited by 60
Rowe, P. S., Matsumoto, N., Jo, O. D., Shih, R. N. J., Oconnor, J., Roudier, M. P., Bain, S., Liu, S., Harrison, J. S., & Yanagawa, N. (2006) · Bone · doi:10.1016/j.bone.2006.04.012 · Cited by 59
FGF23 is elevated in Gambian children with rickets
Prentice, A., Ceesay, M., Nigdikar, S., Allen, S. J., & Pettifor, J. M. (2007) · Bone · doi:10.1016/j.bone.2007.11.014 · Cited by 57
Talmage, R. V., Doppelt, S. H., & Fondren, F. B. (1977) · Calcified Tissue International · doi:10.1007/bf02010351 · Cited by 51
Heike, C. L., Cunningham, M. L., Steiner, R. D., Wenkert, D., Hornung, R. L., Gruss, J. S., Gannon, F. H., McAlister, W. H., Mumm, S. R., & Whyte, M. P. (2005) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30915 · Cited by 50
Brown, E. M., Watson, E. J., Thatcher, J. G., Koletsky, R. J., Dawson-Hughes, B. F., Posillico, J. T., & Shoback, D. (1987) · Metabolism · doi:10.1016/0026-0495(87)90060-6 · Cited by 23
Role of Circulating Fibroblast Growth Factor 23 in the Development of Secondary Hyperparathyroidism
Kazama, J. J., Gejyo, F., Shigematsu, T., & Fukagawa, M. (2005) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2005.00291.x · Cited by 19
Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice
李, 順. (2005) · Okayama University Scientific Achievement Repository (Okayama University) · Cited by 17
Shiraki, M., Gee, M. V., Baum, B. J., & Roth, G. S. (1986) · Endocrinology · doi:10.1210/endo-118-5-2009 · Cited by 13
Flagged first, then by citations
Research works printed but not linked: 4
- Ben-Dov, 2007, J. Clin. Invest., 117, 4003
- Yuan, 2008, J. Clin. Invest., 118, 722
- Xiao, 1998, Am. J. Physiol., 275, E700
- Fisher, 1994, Hum. Mol. Genet., 3, 2053
Cited by
Sorted by citations
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Gansevoort, R. T., Correa-Rotter, R., Hemmelgarn, B. R., Jafar, T. H., Heerspink, H. J. L., Mann, J. F., Matsushita, K., & Wen, C. P. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60595-4 · Cited by 2,213
Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells
Florencio-Silva, R., Sasso, G. R. D. S., Sasso-Cerri, E., Simões, M. J., & Cerri, P. S. (2015) · BioMed Research International · doi:10.1155/2015/421746 · Cited by 2,044
Adams, J. S., & Hewison, M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1773 · Cited by 896
Calcium metabolism in health and disease
Peacock, M. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05910809 · Cited by 886
Regulation of Phosphate Homeostasis by PTH, Vitamin D, and FGF23
Bergwitz, C., & Jüppner, H. (2010) · Annual Review of Medicine · doi:10.1146/annurev.med.051308.111339 · Cited by 741
Metadata
- Authors
- Quarles, L. D.
- Affiliations
- University of Kansas Medical Center (US)
- Corresponding author
- Quarles, L. Darryl
- ORCID
- Quarles, L. Darryl
- Venue
- Journal of Clinical Investigation
- Published
- 2008-12-01
- Volume
- 118
- Issue
- 12
- Pages
- 3820-3828
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2586800
- OpenAlex
- W2165433745
- Cited by
- 459
- References
- 117
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 7 · 2023: 8 · 2022: 13 · 2021: 17 · 2020: 19 · 2019: 37 · 2018: 28 · 2017: 19 · 2016: 22 · 2015: 19 · 2014: 28 · 2013: 26 · 2012: 65
- FWCI
- 5.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR045955, R01-AR-45955, R56AR045955)
- Topics
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Alkaline Phosphatase Research Studies
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- bone endocrine function, mineral metabolism, calcium homeostasis, phosphate homeostasis, fibroblast growth factor 23, 1,25-dihydroxyvitamin D, bone mineralization, hyperphosphatemia, skeletal mass
- MeSH terms
- Fibroblast Growth Factor-23, Animals, Bone and Bones, Calcitriol, Calcium, Energy Metabolism, Fibroblast Growth Factors, Homeostasis, Humans, Phosphates, Bone Density, Hyperphosphatemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review